LOGIN  |  REGISTER

Syra Health to provide Behavioral and Mental Health Screening and Evaluation Services to Law Enforcement Personnel in New Jersey

November 28, 2023 | Last Trade: US$0.37 0.01 -3.17

CARMEL, Ind., Nov. 28, 2023 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare company addressing some of healthcare's most significant challenges by providing innovative services and technology solutions, announced today that it has secured a one-year agreement with the County of Camden Psychological Screening and Evaluation Services to provide mental health screening and evaluations to law enforcement personnel in Camden County, New Jersey.

"Law enforcement personnel are critical to community safety, and face unique challenges that impact their mental well-being," said Dr. Deepika Vuppalanchi, CEO, Syra Health. "By providing specialized psychological screening and evaluation services, Syra Health aims to contribute to the overall improvement of behavioral and mental health within this essential population."

Through the agreement, Syra Health will provide pre-employment psychological testing for police officer recruits, intergovernmental transfers, and evaluations for current employees to determine fitness for duty. The need for these services highlights the range of psychological challenges prevalent among police officers. According to the National Alliance on Mental Illness or NAMI, "Compared to the general population, law enforcement report much higher rates of depression, PTSD, burnout, and other anxiety-related mental health conditions.

"As behavioral and mental health continues to grow in importance, opportunities to provide psychological services to other public sector workers are expected to follow," said Sandeep Allam, Executive Chairman and President, Syra Health "We believe this agreement not only validates Syra Health's experience in providing psychological screenings and evaluations, but also opens doors to providing additional solutions. This includes offerings like Syrenity, which provides comprehensive mental health support."

ABOUT SYRA HEALTH CORP. 

Syra Health is a healthcare company addressing some of healthcare's most significant challenges. Syra Health specializes in behavioral and mental health, digital health, and population health. Syra Health's solutions are centered on prevention, improved access, and affordable care.

For more information, please visit www.syrahealth.com.

FORWARD-LOOKING STATEMENTS

Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." These statements include, but are not limited to, statements relating to the expected use of proceeds, the Company's operations and business strategy and the Company's expected financial results. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements contained in this press release are based on management's current expectations and are subject to substantial risks, uncertainty and changes in circumstances. Investors should read the risk factors set forth in our registration statement on Form S-1 and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by federal securities laws, the Company specifically disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.

For more information, please contact:

For Media Inquiries:
Christine Drury
Communications and Marketing Director
Syra Health
463-345-5180
This email address is being protected from spambots. You need JavaScript enabled to view it.

For Investor Inquiries:
Ben Shamsian
Vice President
Lytham Partners, LLC
646-829-9701
This email address is being protected from spambots. You need JavaScript enabled to view it. 

Assertio

Stock Quote

Featured Stock

Recursion

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....

CLICK TO LEARN MORE

Featured Stock

Amneal Pharmaceuticals

Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB